BrainsWay Announced That Blue Cross Blue Shield Of Louisiana Has Joined The List Of Payors Reducing The Patient Eligibility Requirements For Transcranial Magnetic Stimulation Treatment From Four Failed Medication Trials To Two
BrainsWay Announced That Blue Cross Blue Shield Of Louisiana Has Joined The List Of Payors Reducing The Patient Eligibility Requirements For Transcranial Magnetic Stimulation Treatment From Four Failed Medication Trials To Two
BrainsWay宣佈，路易斯安那州藍十字藍盾已加入付款人名單，將經顱磁刺激治療的患者資格要求從四項失敗的藥物試驗降至兩項
BrainsWay Announced That Blue Cross Blue Shield Of Louisiana Has Joined The List Of Payors Reducing The Patient Eligibility Requirements For Transcranial Magnetic Stimulation Treatment From Four Failed Medication Trials To Two
BrainsWay宣佈，路易斯安那州藍十字藍盾已加入付款人名單，將經顱磁刺激治療的患者資格要求從四項失敗的藥物試驗降至兩項
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。